Weiyu Chen

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 4

Top Topics

Magnetic Resonance

Walled Carbon Nanotubes

Childhood Cancer

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

Journal of immunology (Baltimore, Md. : 1950)

Small (Weinheim an der Bergstrasse, Germany)

Stanford University

University of Queensland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Stanford University Apr 19 2019

United States

POSTDOCTORAL RESEARCH FELLOW :: Radiology

University of Wisconsin-Madison Apr 18 2018 - Apr 18 2019

United States

Research Associate :: The department of Radiology

University of Queensland Nov 01 2017 - Jan 31 2018

Australia

Research assistant :: Australian Institute for Bioengineering & Nanotechnology

Education History

University of Queensland Oct 01 2013 - Oct 01 2017

Australia

PHD :: Australian Institute for Bioengineering & Nanotechnology

Xiamen University Sep 01 2009 - Jun 30 2012

China

MSC

Xiamen University Sep 01 2005 - Jul 01 2009

China

BSC

Publications

Zhou Tian, Qitao Hu, Zhouyi Sun, Ning Wang, Huiling He, Zhe Tang, Weiyu Chen
A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma. ACS nano (2023)
Xinjie Zheng, Yuan Wu, Huali Zuo, Weiyu Chen, Kai Wang
Metal Nanoparticles as Novel Agents for Lung Cancer Diagnosis and Therapy. Small (Weinheim an der Bergstrasse, Germany) (2023)
Huali Zuo, Weiyu Chen, Bei Li, Kewei Xu, Helen J Cooper, Zi Gu, Zhi Ping Gordon Xu
MnAl Layered Double Hydroxide Nanoparticles as a Dual-Functional Platform for Magnetic Resonance Imaging and siRNA Delivery. Chemistry (Weinheim an der Bergstrasse, Germany) 23 (57) (2017)
Jamileh A Nabizadeh, Helga D Manthey, Frederik J Steyn, Weiyu Chen, Alexander Widiapradja, Fazrena N Md Akhir, Glen M Boyle, Stephen M Taylor, Trent M Woodruff, Barbara E Rolfe
The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses. Journal of immunology (Baltimore, Md. : 1950) 196 (11) (2016)